Page last updated: 2024-08-21

pyrazines and Complications of Diabetes Mellitus

pyrazines has been researched along with Complications of Diabetes Mellitus in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (13.64)	18.7374
1990's	3 (13.64)	18.2507
2000's	5 (22.73)	29.6817
2010's	10 (45.45)	24.3611
2020's	1 (4.55)	2.80

Authors

Authors	Studies
Ambrosino, I; Barbagelata, E; Ciarambino, T; Corbi, G; Moretti, AM; Politi, C	1
Asche, CV; Eurich, DT; McAlister, FA; Sandhu-Minhas, JK; Senthilselvan, A; Simpson, S	1
Charbonnel, B; Dejager, S; Schweizer, A	1
Yanai, H	2
Hsieh, CJ; Shen, FC	1
Ain-Shoka, AA; Attia, AS; El-Sahar, AE; Safar, MM; Zaki, HF	1
Bode, BW	1
Resmi, H	1
Huh, JW; Jang, M; Kim, DH; Kim, TW; Park, JS; Suh, JH; Yoon, SY	1
Boddu, ND; Cheskin, LJ; Kahan, S; Kumar, AA; Palamaner Subash Shantha, G; Samson, RJ	1
Hashimoto, N; Okamoto, S; Sadahira, K; Tsukada, Y; Ueda, T; Yokoyama, K	1
Bax, JJ; Bountioukos, MA; Elhendy, A; Krenning, EP; Poldermans, D; Roelandt, JR; Schinkel, AF; Valkema, R; van Domburg, RT; Vourvouri, EC	1
Giannoukakis, N	2
Itogawa, A; Kurono, M; Noguchi, H; Sanjoba, M	1
Mor, R; Pitlik, S; Rosenfeld, JB	1
Braatvedt, G; Corrall, RJ; Newrick, PG; Stansbie, D	1
Bergemann, R; Brandt, A; Siegrist, W	1
Dewailly, P; Heim, J; Jaillard, J	1
Noacco, C; Taboga, C; Tonutti, L	1
Giudicelli, C; Masbernard, A; Massey, J	1

Reviews

4 review(s) available for pyrazines and Complications of Diabetes Mellitus

Article	Year
Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence? Hospital practice (1995), 2013, Volume: 41, Issue:2 Topics: Adamantane; Body Weight; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Drug Therapy, Combination; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Linagliptin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Triazoles; Uracil; Vildagliptin	2013
Defining the importance of daily glycemic control and implications for type 2 diabetes management. Postgraduate medicine, 2009, Volume: 121, Issue:5 Topics: Adamantane; Blood Glucose Self-Monitoring; Circadian Rhythm; Cost of Illness; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Drug Therapy, Combination; Glycated Hemoglobin; Glycemic Index; Humans; Incretins; Pyrazines; Sitagliptin Phosphate; Treatment Failure; Triazoles	2009
Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications. Current opinion in investigational drugs (London, England : 2000), 2006, Volume: 7, Issue:10 Topics: Aldehyde Reductase; Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contraindications; Diabetes Complications; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Pyrazines; Spiro Compounds; Structure-Activity Relationship	2006
Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications. Expert opinion on investigational drugs, 2008, Volume: 17, Issue:4 Topics: Aldehyde Reductase; Animals; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Enzyme Inhibitors; Humans; Pyrazines; Sorbitol; Spiro Compounds; Treatment Outcome	2008

Trials

3 trial(s) available for pyrazines and Complications of Diabetes Mellitus

Article	Year
The durability of sitagliptin in elderly patients with type 2 diabetes. Clinical interventions in aging, 2014, Volume: 9 Topics: Aged; Blood Glucose; Body Mass Index; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Diagnostic Techniques, Ophthalmological; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles; Urinalysis	2014
Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:6 Topics: Blood Glucose; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Pyrazines; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Dysfunction, Left	2003
Suppression of lipolysis in normal man does not inhibit recovery from insulin-induced hypoglycaemia. European journal of clinical investigation, 1993, Volume: 23, Issue:1 Topics: Acetoacetates; Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glycerol; Humans; Hyperlipidemias; Hypoglycemia; Hypolipidemic Agents; Insulin; Lipolysis; Male; Pyrazines	1993

Other Studies

15 other study(ies) available for pyrazines and Complications of Diabetes Mellitus

Article	Year
Gender differences in treatment of Coronavirus Disease-2019. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Dec-03, Volume: 90, Issue:4 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Amides; Antimalarials; Antiviral Agents; Cardiovascular Diseases; Chloroquine; Clinical Trials as Topic; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Diabetes Complications; Female; Humans; Hypertension; Immunity; Immunization, Passive; Immunoglobulins; Lopinavir; Male; Middle Aged; Mortality; Pandemics; Pyrazines; Ritonavir; SARS-CoV-2; Sex Characteristics	2020
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study. BMJ (Clinical research ed.), 2013, Apr-25, Volume: 346 Topics: Comparative Effectiveness Research; Confounding Factors, Epidemiologic; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Hospitalization; Humans; Hypoglycemic Agents; Insurance, Health; Male; Middle Aged; Myocardial Ischemia; Practice Guidelines as Topic; Propensity Score; Proportional Hazards Models; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; United States	2013
Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection. Hepatobiliary & pancreatic diseases international : HBPD INT, 2014, Volume: 13, Issue:5 Topics: Diabetes Complications; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Hepatitis C, Chronic; Humans; Pyrazines; Triazoles	2014
Sitagliptin attenuates transient cerebral ischemia/reperfusion injury in diabetic rats: implication of the oxidative-inflammatory-apoptotic pathway. Life sciences, 2015, Apr-01, Volume: 126 Topics: Animals; Brain Ischemia; Caspase 3; Cytochromes c; Diabetes Complications; Diabetes Mellitus, Experimental; Hippocampus; Hypoglycemic Agents; Interleukin-10; Male; Neuroprotective Agents; Neutrophil Infiltration; Pyrazines; Rats; Rats, Wistar; Reperfusion Injury; Sitagliptin Phosphate; Triazoles	2015
Sitagliptin in treatment of diabetes complicated by chronic hepatitis C. Hepatobiliary & pancreatic diseases international : HBPD INT, 2010, Volume: 9, Issue:4 Topics: Blood Glucose; Comorbidity; Diabetes Complications; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Hepatitis C, Chronic; Humans; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles	2010
The combination of bortezomib and resveratrol may prevent muscle wasting in diabetes. Medical hypotheses, 2011, Volume: 76, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Boronic Acids; Bortezomib; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans; Inflammation; Models, Biological; Muscular Atrophy; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Rats; Resveratrol; Stilbenes	2011
Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures. Neurobiology of disease, 2012, Volume: 46, Issue:1 Topics: Alzheimer Disease; Animals; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Hippocampus; Male; Neurons; Phosphorylation; Primary Cell Culture; Pyrazines; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Sitagliptin Phosphate; tau Proteins; Triazoles	2012
Intentional weight loss and dose reductions of anti-diabetic medications--a retrospective cohort study. PloS one, 2012, Volume: 7, Issue:2 Topics: Adult; Aged; Body Mass Index; Cohort Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; Overweight; Pyrazines; Regression Analysis; Retrospective Studies; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles; Weight Loss	2012
Itraconazole may increase the risk of early-onset bortezomib-induced peripheral neuropathy. International journal of hematology, 2012, Volume: 96, Issue:6 Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Cytochrome P-450 Enzyme System; Dexamethasone; Diabetes Complications; Drug Synergism; Female; Humans; Inactivation, Metabolic; Incidence; Itraconazole; Male; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Protease Inhibitors; Proton Pump Inhibitors; Pyrazines; Retrospective Studies; Risk Factors; Salvage Therapy	2012
Stability and hydrolysis kinetics of spirosuccinimide type inhibitors of aldose reductase in aqueous solution and retardation of their hydrolysis by the target enzyme. Journal of pharmaceutical sciences, 2008, Volume: 97, Issue:4 Topics: Aldehyde Reductase; Diabetes Complications; Drug Stability; Enzyme Inhibitors; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Osmolar Concentration; Pyrazines; Solutions; Spiro Compounds	2008
Indomethacin- and Moduretic--induced hyperkalemia. Israel journal of medical sciences, 1983, Volume: 19, Issue:6 Topics: Aged; Amiloride; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Drug Interactions; Female; Heart Failure; Humans; Hydrochlorothiazide; Hyperkalemia; Indomethacin; Pyrazines	1983
Cost-effectiveness study of a lipid-lowering therapy in hyperlipoproteinaemia type IIb and type IV (Frederickson). PharmacoEconomics, 1993, Volume: 3, Issue:2 Topics: Bezafibrate; Cost-Benefit Analysis; Diabetes Complications; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Models, Econometric; Pyrazines; Treatment Outcome	1993
[Hyperkalemia caused by hyporeninism: role of the hydrochlorothiazide-amiloride combination]. Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1977, Volume: 22, Issue:10 Topics: Aged; Aldosterone; Amiloride; Diabetes Complications; Female; Heart Failure; Humans; Hydrochlorothiazide; Hyperkalemia; Pyrazines; Renin	1977
[Comparison of the efficacy of pantethine, acipimox, and bezafibrate on plasma lipids and index of cardiovascular risk in diabetics with dyslipidemia]. Minerva medica, 1991, Volume: 82, Issue:10 Topics: Bezafibrate; Cardiovascular Diseases; Diabetes Complications; Humans; Hyperlipidemias; Hypolipidemic Agents; Pantetheine; Pyrazines; Risk Factors	1991
Clinical experience with glipizide in the treatment of mostly complicated diabetes. Diabetologia, 1973 Topics: Administration, Oral; Adult; Aged; Blood Cell Count; Blood Glucose; Blood Urea Nitrogen; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Drug Evaluation; Female; Glycosuria; Humans; Hypoglycemia; Hypoglycemic Agents; Lipids; Liver Function Tests; Male; Middle Aged; Pyrazines; Sulfonylurea Compounds	1973